Stewart Campbell

Company: Axial Therapeutics

Job title: CEO

Seminars:

Understand How an Interventional Strategy of Metabolite Removal is Being Translated into a Clinical Setting 3:30 pm

Microbial metabolites have been implicated in many neurological conditions, from neurodevelopmental and behavioral disorders to neurodegenerative diseases Axial, in collaboration with its scientific founder, has established that metabolites derived from the gut microbiome can reach the brain and alter oligodendrocyte maturation, and hence myelination capacity, which can be tied to behavioral changes (Nature, accepted) A…Read more

day: Day Two – Track B – 2